Assessment of Opicinumab in Acute Optic Neuritis Using Multifocal Visual Evoked Potential

Jahr

2018

Autoren

Klistorner A, Chai Y, Leocani L, Albrecht P, Aktas O, Butzkueven H, Ziemssen T, Ziemssen F, Frederiksen J, Xu L, Cadavid D; RENEW MF-VEP Investigators.

Verlag

CNS Drugs. 2018 Dec;32(12):1159-1171.

Link

https://doi.org/10.1007/s40263-018-0575-8

Assessment of Opicinumab in Acute Optic Neuritis Using Multifocal Visual Evoked Potential

Best supportive care for patients with primary progressive multiple sclerosis (PPMS) in Germany prior to ocrelizumab treatment: Final results from the RETRO PPMS study

Harmonized Data Quality Indicators Maintain Data Quality in Long-Term Safety Studies Using Multiple Sclerosis Registries/Data Sources: Experience from the CLARION Study

Eculizumab Use in Neuromyelitis Optica Spectrum Disorders

Long-term effects of siponimod on cardiovascular and autonomic nervous system in secondary progressive multiple sclerosis

COVID-19 and multiple sclerosis: challenges and lessons for patient care